PwC's Next in Health

Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC Strategy&, Sundar Subramanian, on the future health ecosystems and how health leaders will need to completely rethink their strategic footprint to be successful, including:

• Impact of digitization on the health ecosystem
• Emerging key business models health organizations should consider
• Impact and value delivered by a consumer centric health system versus a traditional health system
• Potential changes to the Affordable Care Act and implications for the health ecosystem

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

​Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Principal, Namit Mehta and PwC Strategy& Senior Director, Rohit Harve, on the future of cutting-edge gene and cell therapies. This episode includes:

• Addressing the value and impact of gene cell therapy to improve the quality of life
• Challenges and opportunities with the adoption of a gene cell therapy operating models
• Solutions and emerging technologies health organizations should consider in their approach to deliver gene cell therapies

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the latest vaccine authorized by the Food and Drug Administration (FDA) for emergency use, including:

• Vaccine clinical trials and the efficacy rate on COVID-19 related infections
• Expected uptick in the overall vaccine supply
• Existing COVID-19 vaccines’ effectiveness on COVID-19 variants
• FDA’s updated guidance to address vaccines and emerging COVID-19 variants

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, discuss how consumers are accessing their healthcare post pandemic, including:

• Challenges and implications of differing perspectives among provider executives and consumers on virtual health
• Considerations for delivering a personalized virtual health experience
• New entrants' role in shaping the health system
• Importance and influence of consumer preferences in optimizing the care delivery experience

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos, discuss the risks employers should be aware of, if they decide to adopt a vaccine mandate in the workplace, including:
• Whether employers can require employees to be vaccinated?
• The influence that federal, state and local laws may have on employer mandates
• Different types of employer incentives to encourage employee vaccinations
• The history and growing controversy surrounding vaccine passports

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.